Back to mobile site

Amarin (AMRN) Q4 'Very Strong', Seen as 'Great Tuck-In' for Big Pharma - Jefferies

February 27, 2019 12:52 PM EST Send to a Friend
Jefferies analyst Michael Yee weighed in on Amarin Corporation (NASDAQ: AMRN) following "very strong" Q4 results as the company is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login